Last week, the Trump administration announced a lawsuit against pharmaceutical manufacturer, Gilead Sciences, for profiting off of taxpayer-funded research without […]
Nov
25
News
Nov
12
Off-Label Drug Prescribing: A Common and Controversial Practice
Prescription drugs go through rigorous testing before they are approved by the Federal Drug Administration (FDA) in order to ensure […]
Nov
06
Drugmaker Seeks FDA Approval for First-Ever Alzheimer’s Drug
Pharmaceutical company Biogen has announced plans to seek FDA approval for the first-of-its-kind drug to treat Alzheimer’s disease. Seven months […]
Oct
24
How Doctors Use Psychedelic Drugs to Treat Depression
Johns Hopkins University is now home to the newly-launched Center for Psychedelic and Consciousness Research. Here, doctors are using psychedelic […]
Oct
02
FDA Finds Cancer-Causing Carcinogens in Zantac (Ranitidine), Issues Recall
Pharmacies around the country are pulling Zantac (ranitidine) from their shelves indefinitely. According to new evidence from the Food and […]
Jul
12
Medicare May Increase Payments for Expensive Cancer Drugs
Last year, Medicare officials proposed increasing reimbursement rates for some expensive cancer drugs for patients whose bodies don’t respond to […]
Jan
21
Agencies Affected by the Government Shutdown
Programs like Medicare, Medicaid, and Social Security may be safe from the government shutdown because they’re deemed mandatory and essential […]
May
14
Trump Goes Back on Promise to Let Medicare Negotiate Drug Prices
On Friday, Trump went back on a campaign promise to allow Medicare to negotiate drug prices with drug companies. This […]
Apr
30
To Save Lives, DEA Attempts to Curb Opioid Oversupply
In yet another attempt by the government to curb opioid abuse, the U.S. Drug Enforcement Administration (DEA) plans to rein […]
Apr
10
Medicare to Cover Genetic Testing for Cancer
The Center for Medicare and Medicaid Services (CMS) recently announced that they will cover gene sequencing tests for cancer that […]
